Topic summary
Irish differences from the UK position — what changed since
This is a generated summary. It shows the 5 most-liked posts from a topic of 13, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
On the opening post — agreed on the reasoning, with one qualification.
I keep a log for Irish differences specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
16 likes 10d
p.mbeki, post #5: Waiting times are the most variable and least generalisable thing reported here, and they are worth posting anyway with a region and a date. Adding the caveat now so it does not have to be extracted later. Go to post
Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences.
trough_index, post #3: On the opening post — agreed on the reasoning, with one qualification. I keep a log for Irish differences specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it. Go to post
Adding what did not work for me on Irish differences, since the failures never get written up and they are half the useful information.
Read the full topic (13 posts)
This topic was referenced in
- Pharmacy supply in the UK and the questions you will be askedRegional › UK & Ireland · 105 replies
- MHRA statements, read directly — the long versionRegional › UK & Ireland · 2 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Irish differences from the UK position
Posting this under the heading it deserves: Irish differences from the UK position Everything below is what sits behind that. Trying to establish the boundary conditions on irish differences. The general…
|
+62 | 66 | 993 | 21mo |
|
NHS criteria and how they are applied in practice — the long version
Posting this under the heading it deserves: NHS criteria and how they are applied in practice — the long version Everything below is what sits behind that. A narrow question about NHS criteria, deliberately…
|
+11 | 15 | 11k | 9mo |
|
Coming back to: Private prescribing in the UK: what is actually involved
Private prescribing in the UK: what is actually involved Writing it up because I had to work it out twice and would rather nobody else did. I would like to know what people here actually do about Private…
|
+62 | 67 | 2.1k | 6mo |
|
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated June 2026, because everything in this category expires. The…
|
2 | 5.8k | 15mo | |
|
Private prescribing in the UK: what is actually involved
On the subject in the title: Private prescribing in the UK: what is actually involved Working notes rather than a conclusion. The question about private prescribing that I actually want answered is the second…
|
+66 | 76 | 46k | 14h |
Related topics — sharing the tags personal import, cost per milligram, NHS
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Second pass at: Reimbursement variation across member states
On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. The question about Reimbursement variation across member states that I…
|
+23 | 28 | 45k | 21mo |
|
Second pass at: Manufacturer assistance programmes and their eligibility rules
Second pass at: Manufacturer assistance programmes and their eligibility rules — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
|
+13 | 17 | 1.8k | 16mo |
|
Research-use-only labelling: what it means and what it does not
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. A labelling question, and I would like the answer to be…
|
+100 | 110 | 37k | 5mo |
|
Revisiting: Why a compound being unapproved is not the same as being illegal to possess
On the subject in the title: Revisiting: Why a compound being unapproved is not the same as being illegal to possess Working notes rather than a conclusion. I would like to know what people here actually do…
|
+76 | 82 | 52k | 11mo |
|
About the Pricing category
List prices, negotiated prices, and cost per milligram compared honestly across formats. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+1 | 5 | 18k | 15mo |